MaineMOM improves care for pregnant and postpartum people with opioid use disorder and their infants by integrating maternal and substance use treatment services. Information about MaineMOM service locations and how to refer to services can be found at MaineMOM.org.
MaineMOM Services
MaineCare MaineMOM services will:
- Offer a team-based approach to care, including a perinatal provider, substance use counselor, patient navigator, nurse care manager, behavioral health clinician and recovery coach.
- Provide pregnant and parenting individuals with a treatment plan for counseling, recovery support, and treatment, including medications.
- Provide coordination and a plan for supportive prenatal, delivery, and postpartum care, including family planning.
- Coordinate referrals for other services a person might need during and after pregnancy like health care, housing, or transportation.
MaineMOM Healthcare Partners
The Office of MaineCare Services is collaborating with 19 healthcare sites to test the delivery of MaineMOM Services beginning July 1, 2021. To find a MaineMOM provider, please go to MaineMOM.org.
-
Resources for Clinicians Treating Opioid Use Disorder (OUD) in Pregnancy
-
Treatment Recommendations for Opioid Use Disorder during Pregnancy
- Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder (Office of MaineCare Services, 2021) (PDF)
- White House's Substance Use Disorder and Pregnancy Report (PDF)
- Clinical Guidance for Treating Pregnant and Parenting Individuals with Opioid Use Disorder and their Infants (SAMHSA, 2018)
- FAQ on Substance Use and Pregnancy (ACOG, 2020)
Stigma Awareness and Substance Use Disorders
- Online Resource on Stigma of Substance Use in Pregnancy (March of Dimes)
- Substance Use in Pregnancy: Identifying Stigma and Improving Care (PDF)
- Tool to Improve Provider-Patient Conversations about Substance Use (Maine Medical Association, 2022)
- Words Matter - Terms to Use and Avoid When Talking About Addiction: Self-study module with CME credits from National Institute on Drug Abuse
- Your Words Matter – Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by Substance Use Disorder: Self-study module with CME credits from National Institute on Drug Abuse
Buprenorphine Monotherapy vs. Combination Therapy during Pregnancy
Polysubstance Use During Pregnancy
- Fact Sheet on Polysubstance Use During Pregnancy (CDC, 2020)
- Research Report on Substance Use while Pregnant and Breastfeeding (NIDA, 2020)
- Clinical Recommendations on Marijuana Use During Pregnancy and Lactation (ACOG, 2017)
- Recommended Treatment of Co-Occurring Stimulant Use Disorder and Opioid Use Disorder: Proposed Position of Maine Opioid Response Clinical Advisory Committee (Maine DHHS, 2020)
Screening for Health-Related Social Needs
Urine Toxicology Testing
- Proposed Guidance for Toxicology Testing of Pregnant Patients (Office of MaineCare Services, 2021) (PDF)
- Clinical Drug Testing in Primary Care SAMHSA's Technical Assistance Publication Series 32 (PDF)
Mental Health
- Treatment Guidance for Substance Use Disorder and Co-Occurring Disorders: SAMHSA TAP 42 (SAMHSA, 2020)
- Clinical Recommendations on Screening for Perinatal Depression (ACOG, 2018)
- Webinar Addressing Perinatal Mood and Anxiety Disorders (ACOG, 2019)
- FAQ on Postpartum Depression (ACOG, 2019)
- Tools to Support Postpartum Mental Health (Postpartum Support International)
Breastfeeding & Substance Use Disorders
- Clinical Guidelines for Breastfeeding and Substance Use (ABM, 2015)
- Guide to Support Breastfeeding for People with OUD (NNEPQIN, 2018)
- Marijuana Use in Pregnancy and While Breast Feeding (PDF)
- Research Report on Substance Use while Pregnant and Breastfeeding (NIDA, 2020)
- Beastfeeding and Alcohol, Drugs, and Smoking
Hepatitis C & Substance Use Disorders
- MaineMOM Hepatitis C Treatment Guide (PDF)
- Routine Hepatitis C Virus Screening in Pregnant Individuals | ACOG
- Clinical Recommendations for Hepatitis C Screening in Adults (CDC, 2020)
Pain Management
- Recommended Perioperative Management of Patients Prescribed Buprenorphine for OUD: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020)
- Clinical Recommendations for Managing Pain During and After Delivery (MCPAP, 2019)
Stigma Awareness and Substance Use Disorders
- Online Resource on Stigma of Substance Use in Pregnancy (March of Dimes)
- Tool to Improve Provider-Patient Conversations about Substance Use (Maine Quality Counts, 2018)
Postpartum Reproductive Planning and Contraceptive Care
- Clinical Recommendations on Optimal Postpartum Care (ACOG, 2018)
- Increasing Access to Reproductive Health for People with OUD (Power to Decide, 2018)
Infant Care
- Overview of the Eat, Sleep, Console Model of Care (NICHQ)
- Approaches to Coordinated Care for Mothers and Infants affected by OUD (AAP, 2020)
- Clinical Recommendations for Testing, Managing, and Treating Hepatitis C in Children (AASLD & IDSA, 2020)
Patient Education Materials and Resources
Opioid Use Disorder During Pregnancy
- Fact Sheets for Treating OUD during Pregnancy (SAMHSA, 2018)
- Poster on Pregnant or Thinking of Having a Baby and OUD (SAMHSA, 2019)
Other Substance Use During Pregnancy
- Patient Education Webpage on Marijuana Use and Pregnancy (CDC, 2021) (PDF)
- Patient FAQ on Tobacco, Alcohol and Other Drug Use During Pregnancy (ACOG, 2020)
- Patient Education Webpage Substance Use During Pregnancy (UCSF Health)
- Maine QuitLink to Support Tobacco Cessation
Maine Harm Reduction Services
Maine Intimate Partner Violence Resources
- Sexual Assault Crisis & Support Center
- Maine Coalition Against Sexual Assault
- Maine Coalition to End Domestic Violence
Mental Health Disorders
- Patient Education on Postpartum Depression and Anxiety (ACNM, 2019)
- Patient Education on Perinatal Depression (NIH, 2020)
- Postpartum Depression | ACOG
Contraception
Substance Exposed Infants
-
MaineMOM Advisory Meeting Minutes
-
September 21, 2021
March 16, 2021
December 15, 2020
- Advisory Group & Clinical Committee Meeting Notes (PDF)
- Advisory Group & Clinical Committee Meeting Presentation (PDF)
September 15, 2020
- Advisory Group & Clinical Committee Meeting Notes (PDF)
- Advisory Group & Clinical Meeting Presentation (PDF)
March 10, 2020
June 16, 2020
Maine MOM Model Initiative and Grant Award
Maine was awarded $5.3 million cooperative agreement from the Centers for Medicare and Medicaid (CMS) to participate in the Maternal Opioid Misuse (MOM) model. See the CMS MOM Press Release or the Maine DHHS MOM Award Press Release for more information about the award.
The MaineMOM initiative aims to:
- Implement a “No wrong door" approach to screening, welcoming, and engaging women in care
- Design a system of treatment and recovery for mothers, using a medication first model of Medication Assisted Treatment (MAT)
- Increase access to evidenced-based care by integrated perinatal and substance use healthcare teams
- Coordinate care for pregnant women and mothers with substance use disorders within local communities and across the state of Maine
- Conduct a public outreach campaign aimed at increasing awareness of supportive services and reducing stigma for pregnant women and mothers
See the MaineMOM FactSheet (PDF) for a summary of the model.
Questions?
Email the MaineMOM@maine.gov for questions about the initiative, upcoming events, and meetings.
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award with 100 percent funding by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by CMS/HHS, or the U.S. Government.